Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01966523 · ClinicalTrials.gov registry record · Phase 2

A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia

A Phase 2 study, sponsored by Hebrew SeniorLife.

Completed
Registry status
Phase 2
Development phase
62
Enrollment target

NCT01966523 is a Phase 2 study that has completed, run by Hebrew SeniorLife. The registered enrollment target is 62 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01966523, a Phase 2 study, has completed, sponsored by Hebrew SeniorLife.

COMPLETED
Registry status
Phase 2
Development phase
62 participants
Enrollment target

Study Summary

To conduct a pilot study of cluster randomized clinical trial of an practice intervention to improve the quality of care for suspected lower respiratory and and urinary tract infections among 60 nursing home residents with advanced dementia living in 4 facilities (2 matched intervention/control pairs) for 12 months. We hypothesize that 1. In the intervention compared to the control facilities there will be a trend towards a greater proportion of infections for which antimicrobials were initiated appropriately, and 2. in the intervention compared to the control facilities there will be a trend towards higher proxy satisfaction with decision-making, fewer hospital transfers, and lower antimicrobial exposure.

Interventions

  • OTHER Control
  • BEHAVIORAL Intervention

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2013-10
Est. Completion 2016-02
Phase Phase 2

Sponsor

Hebrew SeniorLife

32 total trials

What the Registry Record Tells You About NCT01966523

The ClinicalTrials.gov registry entry for NCT01966523 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hebrew SeniorLife, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT01966523 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01966523 about?

NCT01966523 is a clinical study titled "A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia". To conduct a pilot study of cluster randomized clinical trial of an practice intervention to improve the quality of care for suspected lower respiratory and and urinary tract infections among 60 nursing home residents with advanced dementia living in 4 facilities (2 matched intervention/control pair...

What is the current status of trial NCT01966523?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2013-10. Estimated completion is 2016-02.

What interventions are being tested in trial NCT01966523?

The interventions under investigation include: Control (OTHER), Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01966523?

This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.